EUVIMEDEUVIMED entdecken
Open Access

Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma

Wenping Song, Xuan Wu, Shuai Wang, Martin P Barr, María Rodríguez, In-Jae Oh, Yingxi Wu, Ding Li

Translational Lung Cancer Research · 2023-12 · 12 (12) · 2476-2493

DOI: 10.21037/tlcr-23-685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2023-12. Verfasst von Wenping Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung adenocarcinoma (LUAD) is the most common histological subtype of non-small cell lung cancer (NSCLC), with poor treatment outcomes worldwide. Dynamin-related protein 1 (DRP1), which is encoded by the dynamin 1-like (DNM1L) gene, acts as a regulator of mitochondrial fission and plays crucial roles in tumor initiation and progression. However, the clinical value and immune regulation of DNM1L in LUAD have not been explored.

Methods

We comprehensively analyzed the expression of DNM1L in the LUAD cohort of the Human Protein Atlas (HPA) and the University of The ALabama at Birmingham CANcer data analysis Portal (UALCAN) databases. Kaplan-Meier plotter, in addition to the PrognoScan database, was used to estimate the correlation between DNM1L expression and survival outcome of LUAD patients. The association between the immune tumor microenvironment (TME) and DNM1L expression in LUAD was evaluated based on the Tumor IMmune Estimation Resource (TIMER)2.0 database. Finally, the functions of DNM1L were validated in vitro experiments, including reverse transcription-quantitative polymerase chain reaction (RT-qPCR), western blot, wound healing assays, and transwell assays.

Results

DNM1L was overexpressed in LUAD compared to healthy control tissues and was regarded as an independent prognostic factor. Overexpression of DNM1L was significantly related to clinical variables and poor survival outcomes of LUAD patients. Moreover, DNM1L expression was positively associated with the expression of key genes involved in the regulation of immune cell subsets, including T helper (Th)2 cells, Th cells, B cells, CD8 T cells, dendritic cells, and mast cells. In contrast, DNM1L was negatively correlated with the infiltrating levels of myeloid dendritic cells and B cells. Furthermore, DNM1L may play a role in regulating immune cell infiltration and have prognostic value in LUAD patients. Finally, the in vitro experiments showed that increased DNM1L significantly promoted the proliferation and migration of LUAD cells.

Conclusions

This study suggested that DNM1L may play an important role in regulating the proliferation and migration of LUAD cells as well as the infiltration of tumor-related immune cells, which suggests DNM1L was a potential therapeutic target in LUAD. Further studies are however warranted to define its exact mechanism of action and potential therapeutic significance in LUAD patients.

Schlagwörter

Stichwörter der Autor:innen

Dynamin 1-like (DNM1L)biomarkerimmunelung adenocarcinoma (LUAD)prognosis

Autor:innen und Institutionen

  • Department of Pharmacy, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Henan Engineering Research Center for Tumor Precision Medicine and Comprehensive Evaluation, Henan Cancer Hospital, Zhengzhou, China.
  • Henan Provincial Key Laboratory of Anticancer Drug Research, Henan Cancer Hospital, Zhengzhou, China.
  • Department of Internal Medicine, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Department of Respiratory and Critical Care Medicine, Henan Provincial Chest Hospital, Zhengzhou, China.
  • Thoracic Oncology Research Group, School of Medicine, Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, St. James's Hospital and Trinity College Dublin, Dublin, Ireland.

Zitieren

APA

Song, W., Wu, X., Wang, S., Barr, M. P., Rodríguez, M., Oh, I. J., Wu, Y., & Li, D. (2023). Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma. Translational Lung Cancer Research, 12(12), 2476-2493. https://doi.org/10.21037/tlcr-23-685

Vancouver

Song W, Wu X, Wang S, Barr MP, Rodríguez M, Oh IJ, et al. Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma. Translational Lung Cancer Research. 2023;12(12):2476-2493. doi:10.21037/tlcr-23-685

BibTeX
@article{Song2023,
  author = {Song, Wenping and Wu, Xuan and Wang, Shuai and Barr, Martin P and Rodríguez, María and Oh, In-Jae and Wu, Yingxi and Li, Ding},
  title = {Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma},
  journal = {Translational Lung Cancer Research},
  year = {2023},
  volume = {12},
  number = {12},
  pages = {2476--2493},
  doi = {10.21037/tlcr-23-685}
}
Kostenlos starten →